Description
Amevive is indicated for the treatment of adult patients with moderate to severe chronic plague psoriasis who are candidates for systemic therapy or phototherapy.
$9,441.62
Amevive is indicated for the treatment of adult patients with moderate to severe chronic plague psoriasis who are candidates for systemic therapy or phototherapy.
Active substance | ALEFACEPT |
---|---|
Amount in a package | 15 мг / 0.5 мл |
Manufacturer | MEDISON PHARMA LTD |
Producing country | Israel |
You must be logged in to post a review.
Reviews
There are no reviews yet.